USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity

James F Burrows1, Alyson A Kelvin, Cheryl McFarlane

  • 1Division of Infection and Immunity, Centre for Cancer Research and Cell Biology, School of Biomedical Sciences, Queen's University Belfast, University Road, Belfast BT7 1NN, Northern Ireland.

Insights

The deubiquitinating enzyme USP17 inhibits Ras protein activation by deactivating Ras-converting enzyme 1 (RCE1). This blocks Ras membrane localization and downstream signaling, impacting cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Proto-oncogene Ras requires post-translational modifications for membrane localization and function.
  • Cleavage of the Ras CAAX motif by Ras-converting enzyme 1 (RCE1) is a critical modification step.

Purpose of the Study:

  • To investigate the role of the deubiquitinating enzyme USP17 in regulating Ras processing and activation.
  • To elucidate the mechanism by which USP17 affects RCE1 activity and downstream signaling.

Main Methods:

  • Assessing Ras membrane localization and activation via Western blotting.
  • Measuring phosphorylation of downstream kinases MEK and ERK.
  • Co-localization studies of USP17 and RCE1 at the endoplasmic reticulum.
  • Experiments in RCE1-null cells to confirm USP17's mechanism.

Main Results:

  • USP17 expression inhibits Ras membrane localization and activation.
  • USP17 blocks phosphorylation of MEK and ERK.
  • USP17 deubiquitinates and inactivates RCE1, leading to these effects.
  • USP17 and RCE1 co-localize at the endoplasmic reticulum.
  • USP17's inhibitory effects are absent in RCE1-null cells.

Conclusions:

  • USP17 negatively regulates RCE1 activity through deubiquitination.
  • USP17 modulates Ras processing and activation by controlling RCE1 function.
  • This mechanism impacts Ras-driven signaling pathways and cellular proliferation.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...